• 1

Find the latest funding information here.

  • 23/10/2020


    Allecra Therapeutics Announces Late-breaker Presentation of Phase 3 ALLIUM Trial with Cefepime-Enmetazobactam in cUTIs at IDWeek 2020
    Download PDF
  • 25/02/2020
    Allecra Therapeutics Announces Positive Top-Line Results for Phase 3 ALLIUM Clinical Trial of EXBLIFEP® for Complicated Urinary Tract Infections
    Download PDF
  • 03/09/2019
    Allecra Therapeutics to Present Data at ASM/ESCMID 2019 Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance
    Download PDF
  • 22/08/2018
    Allecra Therapeutics successfully enters next development phase
    Download PDF
  • 17/04/2018
    Allecra Therapeutics to present data at 28th European Congress of Clinical Microbiology and Infectious Diseases
    Download PDF
  • 26/03/2018
    Allecra Therapeutics announces Positive Top-Line Results from Phase 2 CACTUS Study of its Lead Candidate, Enmetazobactam, in Combination with Cefepime to treat complicated Urinary Tract Infections (cUTI)
    Download PDF
  • 03/04/2018
    Allecra Therapeutics announces participation at the H.C. Wainwright annual global life sciences conference in Monte Carlo, Monaco on April 8-10,2018
    Download PDF
  • 04/05/2017
    Allecra Therapeutics Strengthens Leadership Team with Appointment of New Chairman and Chief Medical Officer
    Download PDF
  • 4/12/2017
    Allecra Therapeutics Announces New Staged Financing Deal to Take the Company Through to End of Phase 3
    Download PDF
  • 1

Scientific Information

Journal Publications


Conference Poster  


Allecra Therapeutics GmbH
Wallbrunnstr. 24
79539 Lörrach



If you have any questions about our work,
please feel free to contact us.

All rights reserved
Copyright 2018
Allecra Therapeutics SAS